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INTRODUCTION
Injection drug use continues to place women at risk for HIV through both risky injecting practices and risky sexual behavior with male injection drug users (IDUs). 1 Human immunodeficiency virus (HIV) infection is more closely tied to drug injection among women than men; 57% of all acquired immunodeficiency syndrome (AIDS) cases among women have been attributed to injection drug use or sex with IDU partners, compared with only 31% among men.
women and their partners as potential influences on many aspects of behavior, including drug use, injecting risk behaviors such as syringe sharing, and protective behaviors such as attendance at syringe-exchange programs (SEPs). In one study, female IDUs were more likely than men to share injecting equipment with their sexual partners. 8 Another study comparing in-and out-of-treatment female injectors found that although 28%-63% reported sharing syringes with a sexual partner, only 4%-13% reported distributive syringe sharing, an indication that the majority of women who shared with their partners injected with their partners' used needles rather than injecting first. 9 In addition, a study of women and men in methadone treatment found that women were more likely than men to report a combination of sexual and injecting risk. 7 These studies indicated that, for women, injection drug use risk behavior is likely strongly influenced by their sexual relationships and the sharing norms of those relationships.
SEP attendance is one effective means to reduce injection-related HIV risk, including syringe sharing, [10] [11] [12] [13] [14] [15] [16] and has been associated with lower HIV seroincidence rates. 17 Power differentials between women and men might be expected to manifest in relationship norms and dynamics and consequently in SEP attendance. For example, female injectors who are dependent on male partners to obtain drugs and syringes may be less likely to attend SEPs; it may be the male's job to go to the SEP. Alternatively, SEP attendance may be considered health-seeking behavior; thus, women may be more likely than their male partner to participate in the SEP. However, among the few studies that have examined gender differences in frequency of SEP use, most have found no gender difference, 18, 19 although one study did find that women were less likely to use the SEP. 20 Secondary syringe exchange, which occurs when individuals exchange syringes used by others, may be important for understanding and assessing individual and network risk. As Valente and colleagues 19 noted, although direct use of SEPs (no secondary exchange) may benefit individual users through contact with SEP staff and services, secondary exchange may benefit the larger IDU network by increasing the number of clean syringes in the community and removing dirty works from circulation. Perhaps in recognition of this potential, according to the most recent survey of 127 SEPs in the United States (of 154 in existence in 2000), 91% permitted secondary exchange; of these, 90% encouraged the practice. 21 In their study of IDUs in Baltimore, Maryland, Valente and colleagues 19 reported that women who engaged in secondary exchange were significantly more likely to become HIV infected, but men were not. The authors suggested that the heightened risk of these women may be caused in part by increased risk from overlapping sexual and drug use partnerships. Whether results found by Valente and colleagues 19 reflect behaviors unique to Baltimore, reflect general characteristics of SEP use among women IDUs, or are markers of greater risk among female IDUs in general has not been determined.
In this study, we examined whether sexual partner IDU status, injecting risk behavior, or sexual risk behavior were associated with secondary syringe exchange among female and male IDUs. Given that female IDUs are more likely than their male counterparts to be involved in sexual relationships with other IDUs, we expected that steady-partner IDU status would be more strongly associated with secondary exchange among women than men. Based on the findings by Valente et al., 19 we also expected that sexual risk behavior would be more strongly associated with secondary exchange among women compared to men.
METHODS

Sample
Data for this analysis came from a study that assessed the impact of California law Assembly Bill (AB) 136 on SEPs and their clients. AB136 is a California state law that, as of January 2000, granted local entities the authority to legalize SEPs pursuant to a declaration of a local emergency caused by a local public health crisis. To assess the impact of this law on client risk behavior, a convenience sample of 25 clients from 23 SEPs in 14 California counties was selected in 2001. This represented 23 of 24 existing SEPs in California that year.
To achieve as representative a sample as possible given logistical difficulties, the goal at each SEP was to recruit clients proportional to the amount of clients each site usually serves. To achieve this goal, the executive directors of each SEP were asked the number of clients each of its sites served per week. The proportion of the SEP's clients served by each site was used to determine approximately how many clients were needed to recruit at each site to reach 25 participants at each SEP. Subsequent samples of SEP clients were recruited and assessed in 2002 and 2003.
Eligibility criteria included presenting at an SEP to exchange syringes, selfreport of any injection drug use in the last 30 days, and willingness to be tested for HIV. A total of 586 SEP clients were interviewed; 55 individuals were interviewed but did not report injection drug use in the past 30 days and were thus excluded from the analysis sample. The sample for this analysis included 531 SEP clients (175 women and 356 men) who completed an interview during the first wave of this study from May to December 2001.
Following HIV pretest counseling and testing (using Orasure saliva test), a brief HIV risk behavior assessment was administered using computer-assisted personal interview in a face-to-face, private interview (Questionnaire Development System, NOVA Research, Bethesda, MD). The assessment included items on HIV risk behaviors (i.e., drug injection and sexual practices), HIV and AIDS knowledge, medical history, incarceration history, and utilization of SEPs and other social and medical services. The research protocol was approved by the institutional review boards at RAND; University of California, San Francisco; and the University of California, Davis. All participants provided informed consent to participate in the study.
Measures
Secondary syringe exchange was determined from the question, "How many different people did you exchange needles for (not including yourself)?" Respondents answered in reference to the day of the interview if syringes were exchanged that day or to the last time the SEP was used if syringes were not exchanged the day of the interview. This was recoded as a dichotomous variable (yes-no). This measure included individuals who returned syringes for others without the express intention of providing clean syringes to those for whom the exchange was made.
Sexual partner status was determined from participants' reports of whether they had a steady sex partner in the last 6 months and whether that partner injected drugs. Three categories were created: steady sex partner injects, steady sex partner does not inject, or no steady sex partner. We used steady sex partner does not inject as the reference category because we are interested in whether the injecting status of individuals' partners is an important influence on secondary exchange.
Syringe sharing was measured with two variables. Receptive syringe sharing was determined from the question, "In the last 30 days, how many times did you inject using syringes/needles that you know had been used by someone else (including a close friend or lover)?" Distributive syringe sharing was determined from the question, "In the last 30 days, how many times did you give or loan syringes/needles that you had used to someone else (including a close friend or lover), who then used them?" These variables were collapsed into two categories, yes or no.
Reuse of syringes was determined from the question, "On average, when you get a brand new, never-used needle, how many times do you inject with it before you get rid of it?" This variable was dichotomized into yes or no reuse.
Sexual risk behavior was measured using two variables. Participants were asked what percentage of the time they used condoms for vaginal and anal sex in the past 6 months. Responses were categorized as a dichotomous variable based on 100% condom use for all sex acts or less than 100% protected acts; yes indicated unsafe sex, and no indicated 100% safe sex. Respondents were also asked whether they engaged in sexual acts to receive money or drugs in the past 30 days (yes-no).
To determine HIV status, specimens were analyzed for HIV antibodies using enzyme immunoassay. Specimens positive by enzyme immunoassay were confirmed using Western blot assay. Criteria for a seropositive Western blot result were the presence of reactive bands at two of the following locations, as described by the Centers for Disease Control and Prevention 22 : p24, gp41, and gp120/160. Injection frequency has been associated with SEP utilization 18, [23] [24] [25] [26] ; thus, we examined this variable. Injection frequency was measured using three categories of reported use in the past 30 days: less than 60 times, 60-89 times, or 90 or more times. We also examined SEP attendance frequency because more frequent attendance may be associated with syringe relay. 19 SEP frequency was measured as the number of times individuals reported attending an SEP in the past 30 days (continuous). We controlled for length of injecting career, measured using a dichotomous variable ( < 10 years, 10 + years), because more seasoned injectors may feel more comfortable distributing syringes for others. We also included demographic measures, including race/ethnicity, age, education, and income, as control variables. All measures were based on self-report.
Analysis We first examined bivariate gender differences in the dependent and independent variables using the chi-square procedure for categorical variables and the one-way analysis of variance procedures for continuous variables. We then conducted multivariate logistic regression models to predict the odds of being a secondary exchanger separately for women and men to determine gender differences in the influence of steady sex partner status and syringe sharing on syringe relay. Demographic and control variables associated with secondary exchange in bivariate analyses at the P < .10 level (tested separately for each gender) and all variables of theoretical interest were included in both logistic regression models. All analyses were conducted using SPSS 11.5 (SPSS Inc., Chicago, IL). Table 1 shows bivariate gender differences in demographics, partner status, drug use, and SEP-related variables. There were no gender differences in race/ethnicity, education, and income in this sample. Men were older on average than women (42 vs. 39 years, respectively; P < .01). Women were significantly more likely to engage in secondary exchange than men (47.4% vs. 33.1%, respectively; P < .01). As expected, more women than men had steady sexual partners who injected drugs (42.9% vs. 27.2%, respectively; P < .01). More women than men reported injecting 90 or more times in the previous month (42.9% vs. 32.6%, respectively; P < .05), and women attended the SEP slightly more often than men in the previous month (3.8 times vs. 3.2 times, respectively; P < .05). There were no gender differences in distributive or receptive syringe sharing in the previous 30 days. Although there were no gender differences in the proportion engaging in unsafe sexual acts, women were significantly more likely than men to have exchanged sex for money or drugs (22.9% vs. 4.2%, respectively; P < .001). HIV prevalence in the total sample was low (less than 6%) and not significantly different between women and men. Table 2 shows the results of the logistic regression models predicting the odds of engaging in secondary exchange in the past 30 days. Among both women and
RESULTS
TABLE 2. Logistic regression predicting secondary exchange for women and men
Only variables significant at the P < .10 level and variables of theoretical interest were included in multivariate models. * P < .01. † P < .10. ‡ P < .05. § P < .001. men, the odds that whites exchanged syringes for others were significantly higher than for African Americans. Among women, those who reported injecting with syringes previously used by others in the past 30 days (receptive sharing) were less likely to engage in secondary exchange than those who did not share, although this was significant at the P < .10 level. Alternatively, those who reported giving their used syringes to others (distributive sharing) were more likely to have exchanged others' syringes than those who did not give out their used syringes (P < .05). Women's steady partner IDU status was not related to secondary exchange, and neither measure of sexual risk was associated with secondary exchange among women. Among men, those with an injecting sexual partner were more likely to engage in secondary exchange than those with a noninjecting partner (P < .001). In addition, men who reused syringes were less likely to engage in secondary exchange (P < .001). Neither the sharing nor the sexual risk behavior variables were associated with secondary exchange among men.
Models were also run on the entire sample; these included interaction terms for gender by variables of interest (partner status, receptive sharing, and distributive sharing). These combined interaction models confirmed statistically significant differences between women and men for distributive sharing and partner injecting status (analyses not shown). To examine gender differences in risk behavior in this subgroup, we also compared females and males who reported engaging in secondary exchange. Bivariate analyses revealed no gender differences in sexual risk behavior, number of sexual partners in the past 6 months, syringe-sharing behavior, the number of people for whom they exchanged syringes, the number of syringes they planned to keep for themselves, or the number of syringes they planned to give away or sell (analyses not shown).
DISCUSSION
Gender differences in secondary syringe exchange were found in this study, yet no gender difference was found in HIV prevalence. Contrary to our expectations, having an IDU steady sexual partner was not associated with secondary syringe exchange among women, but having an IDU sex partner was independently associated with secondary exchange among men. Perhaps when male IDUs engage in secondary exchange, they are doing so primarily for their sexual partners, but women may be more likely to exchange for other network members in addition to sexual partners. It is difficult to interpret this finding without having more information about the social networks and network member behavior of the sample.
Although there were no gender differences in either distributive or receptive syringe sharing, these factors were associated with secondary exchange among women. Secondary exchange was potentially indicative of greater network risk among women: Being a secondary exchanger was positively associated with distributive sharing. On the other hand, secondary exchange among women was inversely associated with use of others' syringes (marginally significant at P < .10), possibly indicating self-protective behavior associated with secondary exchange. In contrast to the Baltimore study, 19 we found that secondary exchange among women was associated with greater risk for their social networks rather than for them individually. Neither type of syringe sharing was associated with secondary exchange among the men in this study; thus, it is unlikely that secondary exchange confers either network risk or personal protection from HIV among male injectors. Engaging in secondary exchange may be an indicator of personal assertiveness, power, and initiative among women. Women who exchange for others are more likely to have access to their own clean syringes, thus providing them the means to protect themselves. In addition, agency and assertiveness associated with attending the SEP and obtaining syringes may enable women who use with others to ensure they get high before their other partners/network members. However, this same self-protective behavior may translate into greater network risk in that women seem not only to exchange syringes for others, but also to share their own used syringes with them. Finally, there may be some selection bias in SEP attendance. Women who attend the SEP and exchange for others, compared to women whose partners attend the SEP and exchange for them, may have greater power and assertiveness in their sexual relationships, potentially explaining the finding that secondary exchange was associated with having an IDU sexual partner for men, but not for women.
The findings indicated that female IDUs who exchange syringes for others are unlikely to be at greater HIV risk from injecting practices within their drug-using network. In addition, although Valente and colleagues 19 suggested that the increased HIV risk among women who engage in secondary exchange may be because of sexual partner status or sexual risk behavior, we did not find evidence that this was the case in the California sample. We found no association between sexual risk behavior (lack of condom use and exchanging sex for money or drugs) and secondary exchange for either women or men.
One possible explanation for the differing results is measurement of secondary exchange. Valente and colleagues measured what they termed syringe relay by linking individual identification numbers with bar codes affixed to syringes acquired and returned. Those who returned syringes originally issued to someone else were considered syringe relayers. Individuals were not asked whether they returned syringes for others.
This study is subject to several limitations. This was a convenience sample from SEPs in California, which means that we do not know if these results are generalizable to other IDU populations or SEP users in California. Risk behavior and social network characteristics in the California sample of SEP clients may be distinct to this population. We also have little information about potential selection bias because we do not have precise information on individuals who refused to participate. Because of differences in how SEPs operate (e.g., some have multiple sites, some conduct delivery from mobile vans, some are at fixed locations), it was impossible to collect comprehensive refusal data. Anecodotal reports of reasons for refusal include no time to undergo study procedures (which took between 30 and 45 minutes), not interested in participating in research study, and not interested in receiving an HIV test. In addition, there were twice as many men than women in the sample; although this is consistent with gender distributions among injectors, in methadone clinics, and in SEPs, we do not know whether there were significant gender differences between those who refused and participants.
These data are cross-sectional and measure only one SEP visit. Although we had HIV serostatus, there was no information on HIV seroconversion over time. Therefore, we were not able to compare seroconversion in this sample with that in the Valente et al. sample. 19 In addition, only limited data were available on drugusing network members; thus, we were not able to measure directly how social network characteristics might influence secondary exchange behavior. Finally, the exposure variables are self-reported, which means they are vulnerable to biases resulting from social desirability, poor recall, and intoxication. 27 However, multicenter research on injection drug users has shown that self-report is very reliable among drug users not recruited in clinical settings. [28] [29] [30] Other studies 31, 32 and our own [33] [34] [35] have found substantial operational and contextual differences among SEPs and the communities in which they operate. In California, there are potentially many important differences in both SEP characteristics and community context, and we continue to compile data that will permit in-depth analyses of these factors and HIV risk and secondary exchange. However, such analyses are beyond the scope of this article.
Our data suggest that secondary exchange does not elevate HIV risk for female SEP clients, and there is some evidence that secondary syringe exchange is associated with lower HIV risk behaviors among men. More detailed information on the social networks of SEP users is needed to understand the interaction between network dynamics and SEP utilization patterns and how these might lead to different HIV risk levels for women and men. The next wave of the California Syringe Exchange Program Study includes additional questions about social network members, which will be useful in addressing some of these questions.
